drugset / Trial / NCT06826989

A Study of MK-8527 in Healthy Adult Participants (MK-8527-013)

NCT06826989

Phase 1 Completed 8 enrolled Merck Sharp & Dohme LLC
NaSingle-groupOpen-labelBasic science

Summary

The goal of this study is to learn how \[14C\]MK-8527 moves through a healthy person's body over time. Researchers will study how \[14C\]MK-8527 is absorbed by the body, broken down by the body, and how it leaves the body.

Timeline

Start
2025-03-19
Primary completion
2025-06-04
Completion
2025-06-04

Drugs

EvaluationDrugModalityDoseRoute
Subject MK-8527 Small molecule Oral

Indications

No indication recorded.